BioSpace News Archive

Microdispensing of adhesives

Perfect dispensing results in the μl area using the endless piston principle

September 17, 2018
·
6 min read
Biotech Beach

Disruptions and Future Trends Shaping Bio-Tech Industry Investments Reveal Los Angeles as New Node

Event Bolsters Los Angeles as a National Biotech Hub

September 17, 2018
·
2 min read
Policy

FDA’s Gottlieb Issues Agency Marching Orders to Fight Antimicrobial Resistance

U.S. Food and Drug Administration (FDA) Commissioner Scott Gottlieb gave a talk at The Pew Charitable Trusts on Friday, September 14, outlining the agency’s new approach to dealing with antimicrobial resistance (AMR).

September 17, 2018
·
3 min read
·
Mark Terry
Drug Development

AstraZeneca Plans to Seek Regulatory Approval for COPD Drug PT010 Following Phase III Trial

Following a setback in a chronic obstructive pulmonary disease (COPD) clinical trial in August, AstraZeneca unveiled data from a separate trial on Sunday that showed its triple combination therapy PT010 outperformed its dual-therapy rivals eight of nine times.

September 17, 2018
·
3 min read
·
Alex Keown
Drug Development

FDA Lifts Partial Clinical Hold on Mersana Therapeutics’ ADC XM-1522

Shares of Cambridge, Mass.-based Mersana Therapeutics are up more than 7 percent in premarket trading after the company announced that it will be able to continue with its Phase I trial studying the antibody drug conjugate XMT-1522 as a potential treatment for some breast cancer patients.

September 17, 2018
·
2 min read
·
Alex Keown
Drug Development

Pfizer News: Alopecia Drugs Show Promise, and Company Inks Deal with Atomwise

Pfizer announced results from its Phase IIa clinical trial of PF-06651600 and PF-06700841 in alopecia areata (AA).

September 17, 2018
·
3 min read
·
Mark Terry
Business

CRISPR Therapeutics and ViaCyte Collaborate to Tackle Type 1 Diabetes

CRISPR Therapeutics and ViaCyte are collaborating to discover, develop and commercialize a gene-edited allogeneic stem cell therapy or therapies for diabetes.

September 17, 2018
·
3 min read
·
Mark Terry
Business

Realm Therapeutics Slashes Staff and Explores Potential Sale as the Company Conducts a Strategic Review

Following a trial failure with its atopic dermatitis treatment, Malvern, Penn.-based Realm Therapeutics has opted to discontinue all of its drug development programs and is considering a potential sale of the company.

September 17, 2018
·
2 min read
·
Alex Keown
Policy

House Rejects Senate Bill Provision to Require Disclosure of Drug Prices in Television Commercials

The U.S. House of Representatives has split with the Senate over requiring pharmaceutical companies to disclose the list price of their prescription medications in television advertisements.

September 17, 2018
·
2 min read
·
Alex Keown
Policy

Genentech and Hemophilia Patients Eye Oct. 4 for Hemlibra Ruling

Hemophilia patients could have an easier time taking their medication if the U.S. Food and Drug Administration (FDA) gives the green light for the newest indication of Genentech’s Hemlibra for patients who do not have Factor VIII inhibitors.

September 17, 2018
·
3 min read
·
Alex Keown